-ISO 9001:2000
   
 

Innovative Technologies

The company's strength lies in its research and formulation development, which has resulted in the development of proprietary technology platforms like Aquatech (painless administration of drugs), Lipisol (enables oily formulation to become water miscible), Matrix (sustained release of small amounts of active ingredient over an extended period of time from the tablet), etc. The formulations developed from these platforms prove to be better than the conventional formulations available in the market.

Every product formulation under these platforms is backed by multi-centric clinical trials conducted at reputed institutions. Some of the products developed from these innovative technologies include Aqua-E omega (water soluble natural vitamin E), FENO-TG (Micro-solve technology), Sitrus-LA (slow release of vitamin C), etc.

It is through constant R&D that the company could develop Dynapar AQ 1 ml, which is the world's first ever painless diclofenac injection. The company enjoys patent of Dynapar 1 ml, the only 1 ml Diclofenac injection, in more than 20 countries; other countries would soon follow. (Patent filed in 99 countries).

 
- - -
Overview
AquaTech
Buccal Paste
Decompaction
Matrix
Lipotech
Microsolve
Pre Filled Syringe (PFS)
LiquiCaps
Lipisol
Intraoral Drug Delivery
Parenteral Emulsion
Duophase
 
Innovative Technologies
       
Aquatech
Buccal Paste
Decompaction
Matrix
       
Lipotech
Microsolve
Pre Filled Syringes
LiquiCaps
       
Lipisol
Intraoral
Drug Delivery
Parenteral Emulsion
Duophase
       
   

Home | Company | Products | Technologies | International Business | Media Releases | Human Resources | Business Alliances | Research Publications

Copyright © 2009 Troikaa Pharmaceuticals Ltd. - Disclaimer